Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment

Crispr Therapeutics and Vertex Pharmaceuticals got U.S. regulatory approval for a sickle-cell disease treatment based on the gene-editing technology Crispr.